Jump to content

Draft:Antonio Ibarra

From Wikipedia, the free encyclopedia

Dr. Antonio Ibarra is a Professor, Researcher and Coordinator of the Health Sciences Research Center, at the Faculty of Health Sciences at Anáhuac University [1]. He earned his Master's and Doctorate in Sciences in Neuroimmunology from the National Autonomous University of Mexico, in 1994 and 1998, respectively. Dr. Ibarra's thesis focused on the development of neuroprotective strategies following spinal cord injury.

Dr. Ibarra has studied the beneficial effects induced by protective autoimmunity after spinal cord injury, firstly as a postdoctoral fellow in the laboratory of Professor Michal Schwartz at the Weizmann Institute of Science in Israel, and later as a scientist of the Health Sciences Research Center (CICSA) of Anáhuac University.[2]

Education

[edit]

Dr. José Juan Antonio Ibarra earned his Medical Degree on January 21, 1990, from the National Autonomous University of Mexico (UNAM). He obtained his Master's degree in Biomedical Sciences (Immunology) on November 21, 1994, from the Faculty of Medicine at UNAM, graduating with honors. He then completed his Doctorate in Biomedical Sciences (Neuroimmunology) on April 20, 1998, also with honors, from the Faculty of Medicine at UNAM. Additionally, he completed a postdoctoral fellowship in Neuroimmunology from January 8, 2001, to January 4, 2002, at the Laboratory of Neurobiology, Weizmann Institute of Science, Israel.[3]

Career and research

[edit]

Using spinal cord injury models, Dr. Ibarra has published 70 articles and 12 book chapters in prestigious journals and editorials such as PNAS, Journal of Neurotrauma, and Humana Press. Additionally, he has been a reviewer for several international journals, including Brain, Brain Research, Spinal Cord, Neuropsychobiology, Molecules, BMC Neuroscience, European Journal of Pharmacology, Neuroscience Letters, and Medical Science Monitor.

His research lines encompass topics related to the analysis of the autoimmune response against neural constituents after a central nervous system injury [4]; analysis of the immunological function after a central nervous system injury [5][6] [7]; evaluation of various treatments aimed at promoting neuroprotection and neuroregeneration after a central nervous system injury[8] [9] [10] [11] [12]; analysis of the neuroprotective and regenerative effects of the immune system in a cerebral ischemia model [13]; analysis of the immunomodulatory effect of various drugs used after a central nervous system injury [14] [15] [16] [17]; and Immunonutrition. [18] [19] [20]

Awards, recognitions and memberships

[edit]

Dr. Antonio Ibarra's achievements include to be part of Level III in the National System of Researchers. He is a member of the Society for Neuroscience since March 1992 and the Mexican Academy of Sciences, since 2009. He was the winner of the Dr. Jorge Rosenkranz Award 2016 for the study titled "Immunization with modified neural peptides plus scar removal induces a permissive microenvironment and promotes better motor recovery after chronic spinal cord injury" [21], and also the winner of the State Science and Technology Award 2016 in Health Sciences from COMECYT. He receivied the Dr. Everardo Landa Award from the National Academy of Medicine in 2017.

  1. ^ José Juan Antonio Ibarra-Arias | Universidad Anáhuac México. (s. f.). https://www.anahuac.mx/investigacion/jose-juan-antonio-ibarra-arias
  2. ^ Antonio IBARRA | DSc | Anáhuac University, Huixquilucan | Coordinación de Investigación FCS | Research profile. (s. f.). ResearchGate. https://www.researchgate.net/profile/Antonio-Ibarra-6
  3. ^ ORCID. (s. f.-b). https://orcid.org/0000-0003-2489-4689
  4. ^ Zajarías-Fainsod D, Carrillo-Ruiz J, Mestre H, Grijalva I, Madrazo I, Ibarra A. Autoreactivity against myelin basic protein in patients with chronic paraplegia. Eur Spine J. 2012 May;21(5):964-70. https://doi.org/10.1007/s00586-011-2060-7. Epub 2011 Nov 8. PMID: 22057439; PMCID: PMC3337920.
  5. ^ Cruz Y, García EE, Gálvez JV, Arias-Santiago SV, Carvajal HG, Silva-García R, Bonilla-Jaime H, Rojas-Castañeda J, Ibarra A. Release of interleukin-10 and neurotrophic factors in the choroid plexus: possible inductors if neurogenesis following copolymer-1 immunization after cerebral ischemia. Neural Regen Res. 2018 Volume13 doi:https://doi.org/10.4103/1673-5374.238615.
  6. ^ Toscano-Tejeida D, Ibarra A, Phillips-Farfán B.V., Fuentes-Farías A.L., Meléndez-Herrera E. ACAID as a potential therapeutic approach to modulate inflammation in neurodegenerative diseases. Medical Hypotheses 2016; 88: 38-45 https://doi.org/10.1016/j.mehy.2016.01.006.
  7. ^ Ibarra A, Garcia E, Flores N, Martiñon S, Reyes R, Campos MG, Maciel M, Mestre H. Immunization with neural derived antigens inhibits lipid peroxidation after spinal cord injury. Neurosci Lett 2010; 476: 62-65. ISSN: 0304-3940 https://doi.org/10.1155/2013/827517
  8. ^ Martiñón S, García-Vences E, Toscano-Tejeida D, Flores-Romero A, Rodriguez-Barrera R, et al. Long-term production of BDNF and NT-3 induced by A91-immunization after spinal cord injury. BMC https://doi.org/10.1186/s12868-016-0267-6
  9. ^ Ibarra A, Sosa M, García E, Flores A, Cruz Y, Mestre H, Martiñón S, Pineda-Rodriguez B, Gutierrez-Ospina G. Prophylactic neuroprotection with A91 improves the outcome of spinal cord injured rats. Neurosci lett, 2013; 554, 59-63. ISSN: 0304-3940 https://doi.org/10.1016/j.neulet.2013.08.048
  10. ^ Hauben E, Ibarra A, Mizrahi T, Barouch R, Agranov E, Schwartz M. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response https://doi.org/10.1073/pnas.011585298
  11. ^ Martiñon S, García E, Flores N, Gonzalez I, Ortega T, Buenrostro M, Reyes R, Fernandez-Presas AM, Guizar-Sahagún G, Correa D, Ibarra A. Vaccination with a neural-derived peptide plus administration of glutathione improves the performance of paraplegic rats. Eur J Neurosci 2007; 26: 403-412. ISSN: 0953-816X https://doi.org/10.1111/j.1460-9568.2007.05650.x
  12. ^ García E, Silva-García R, Mestre H, Flores N, Martiñón S, . Calderón-Aranda ES, Ibarra A. Immunization with A91-peptide or Copolymer-1 reduces the production of nitric oxide and iNOS gene expression after spinal cord injury. J Neurosci Res 2012, 90 (3): 656-663. ISSN: 0168-0102 https://doi.org/10.1002/jnr.22771
  13. ^ Ibarra A, Avendaño H, Cruz Y. Copolymer-1 (Cop-1) improves neurological recovery after middle cerebral artery occlusion in rats. Neurosci lett 2007; 425: 110-113. ISSN: 0304-3940 https://doi.org/10.1016/j.neulet.2007.08.038
  14. ^ Ibarra A, Hauben E, Butovsky O and Schwartz M. The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats. Eur J Neurosci. 2004; 19: 2984-2990. ISSN: 0953-816X https://doi.org/10.1111/j.0953-816x.2004.03402.x
  15. ^ Ibarra A, Diaz-Ruiz A. Protective effect of cyclosporin-A on spinal cord injury: an overview. Curr Med Chem 2006; 13 (22): 2703-10. ISSN: 0929-8673 https://doi.org/10.2174/092986706778201503
  16. ^ Ibarra, A., Hernandez, E., Lomeli, J., Pineda, D., Buenrostro, M., Martinon, S., Garcia, E., Flores, N., Guizar-Sahagun, G., Correa, D. & Madrazo, I. Cyclosporin-A enhances non-functional axonal growing after complete spinal cord trasection. Brain Res 2007; 1149: 200-209. ISSN: 0006-8993 https://doi.org/10.1016/j.brainres.2007.02.056
  17. ^ Martiñón S, García E, Gutierrez-Ospina G, Mestre H, Ibarra A. Development of protective autoimmunity by immunization with a neural-derived peptide is ineffective in severe spinal cord injury. PLoS ONE 2012, 7(2): e32027. ISSN: 1932-6203 https://doi.org/10.1371/journal.pone.0032027
  18. ^ Romo-Araiza A, Gutiérrez-Salmeán G, Galván EJ, Hernández-Frausto M, Herrera-López G, Romo-Parra H, García-Contreras V, Fernández-Presas AM, Jasso-Chávez R, Borlongan CV, Ibarra A. Probiotics and Prebiotics as a Therapeutic Strategy to Improve Memory in a Model of Middle-Aged Rats. Front Aging Neurosci. 2018 doi: 10.3389/fnagi.2018.00416 https://doi.org/10.3389/fnagi.2018.00416
  19. ^ Leal-Martínez F, Franco D, Peña-Ruiz A, Castro-Silva F, Escudero-Espinosa A A , Rolón-Lacarrier G, López-Alarcón M, De León X, Linares-Eslava M and Ibarra A. Effect of a Nutritional Support System (Diet and Supplements) for Improving Gross Motor Function in Cerebral Palsy: An Exploratory Randomized Controlled Clinical Trial. Foods 2020; 9, 1449; doi. 10.3390/foods9101449. https://doi.org/10.3390/foods9101449
  20. ^ Servín-Casas GA, Romo-Araiza A, Gutierrez-Salmean G, Martinez-Solis E, Ibarra-García AP, Cruz-Martinez Y, Rodriguez-Barrera R, García E, Incontri-Abraham D, Ibarra A. Memory improvement in senile rats after prebiotic and probiotic supplementation is not induced by GLP-1. CNS Neurosci Ther. 2022 Dec;28(12):1986-1992. doi: 10.1111/cns.13951. Epub 2022 Sep 2. PMID: 36052558; PMCID: PMC9627373. https://doi.org/10.1111/cns.13951
  21. ^ Rodríguez-Barrera R, Flores-Romero A, Fernández-Presas AM, García-Vences E, Silva-García R, Konigsberg M, Blancas-Espinoza L, Buzoianu-Anguiano V, Soria-Zavala K, Suárez-Meade P, Ibarra A. Immunization with neural derived peptides plus scar removal induces a permissive microenvironment, and improves locomotor recovery after chronic spinal cord injury. BMC Neurosci. 2017 Jan 5;18(1):7. doi: 10.1186/s12868-016-0331-2. PMID: 28056790; PMCID: PMC5217189 https://pubmed.ncbi.nlm.nih.gov/28056790/
Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Antonio_Ibarra&oldid=1236085919"